sPLA2 (human, recombinant Type X)

Artikelnummer Größe Datenblatt Manual SDB Lieferzeit Menge Preis
Cay10011673-25 25 µg -

6 - 10 Werktage*

526,00 €
 
Secretory phospholipase A2 (sPLA2) (Type X) is a calcium-dependent PLA2 superfamily member that... mehr
Produktinformationen "sPLA2 (human, recombinant Type X)"
Secretory phospholipase A2 (sPLA2) (Type X) is a calcium-dependent PLA2 superfamily member that is encoded by PLA2G10 in humans. It is composed of an N-terminal signal peptide, a highly-conserved calcium-binding loop, a catalytic domain, sPLA2 Type I- and II-specific disulfides that provide stability, and a C-terminal extension. sPLA2 (Type X) is expressed in spleen, thymus, peripheral blood leukocytes, pancreas, lung, and colon, as well as neutrophils and keratinocytes. Upon activation, sPLA2 (Type X) is released into the extracellular space where it acts in a paracrine or autocrine manner and preferentially catalyzes the hydrolysis of phosphatidylethanolamine (PE) and phosphatidylcholine (PC) over phosphatidylserine (PS) at the sn-2 position, liberating the free fatty acid and lysophospholipid, which serve as substrates for the synthesis of bioactive lipid metabolites. sPLA2 (Type X) increases arachidonic acid (Cay-90010, Cay-90010.1, Cay-10006607) release from HEK293 cells and prostaglandin E2 (Cay-14010) levels in HEK293 cells expressing human COX-2 but not COX-1. Pla2g10-/- mice have decreased inflammatory cell infiltration and airway edema in a model of ovalbumin-induced allergic asthma. Airway lining fluid levels of sPLA2 (Type X) are increased in patients with asthma. Cayman's sPLA2 (human, recombinant Type X) protein can be used for enzyme activity assays. The specific activity of Cayman's sPLA2 (human, recombinant Type X) was established using Cayman's sPLA2 Assay Kit (Cay-765001) with 1.48 mM 1,2-bis(heptanoylthio) glycerophosphocholine (Cay-62235) as the substrate.Synonyms: Group 10 secretory phospholipase A2, GXPLA2, Phosphatidylcholine 2-Acylhydrolase 10, PLA2G10, Secretory Phospholipase A2 (human Group X), sPLA2-X. Purity: >90% estimated by SDS-PAGE. Source: Active recombinant human C-terminal His-tagged sPLA2 (Type X) expressed in E. coli. Amino Acids: 43-165. MW: 14.4 kDa. Formulation: (Request formulation change), 20 mM Tris-HCl, pH 8.5, with 10 mM calcium chloride and 10% glycerol. UniProt Accession #: O15496.
Schlagworte: PLA2G10, sPLA2-X, sPLA2-X, GX sPLA2, GX sPLA2, Group X secretory phospholipase A2, Group X secretory phospholipase A2, Group 10 secretory phospholipase A2, Group 10 secretory phospholipase A2, Phosphatidylcholine 2-acylhydrolase 10, Phosphatidylcholine 2-
Hersteller: Cayman Chemical
Hersteller-Nr: 10011673

Eigenschaften

Anwendung: Enzyme assays
Konjugat: No
Spezies-Reaktivität: human
Reinheit: >90% estimated by SDS-PAGE
Format: Solution

Handhabung & Sicherheit

Lagerung: -80°C
Versand: -80°C (International: -80°C)
Achtung
Nur für Forschungszwecke und Laboruntersuchungen: Nicht für die Anwendung im oder am Menschen!
Hier kriegen Sie ein Zertifikat
oder , um Analysenzertifikate anzufordern.
Bewertungen lesen, schreiben und diskutieren... mehr
Kundenbewertungen für "sPLA2 (human, recombinant Type X)"
Bewertung schreiben
oder , um eine Produktbewertung abzugeben.
Zuletzt angesehen